Our main interest is to understand how tumor cells respond to cancer therapy. We explore molecular mechanisms behind cancer pathogenesis and therapy response, and search for biomarkers, which could be used as prognostic and/or predictive factors for treatment and survival. Furthermore, we perform clinical trials based on the generated translational data. Our cancer model is lymphoma.
Read more

Greetings from our traditional summer brainstorm "Lymphoma matters" https://t.co/rdKYC3TG2v

Warmly welcome to this multidisciplinary symposium combining clinical and experimental research organized by… twitter.com/i/web/status/1…

Juuri näin 👍 twitter.com/JWahlfors/stat…

Recent Publications

RSS Feed

No results.